Results 131 to 140 of about 15,721 (211)

NT5DC2 inhibits ferroptosis by stabilizing ACSL3 in bladder cancer. [PDF]

Cell Death Discov
Niu S, Yang P, Yao Y, Tang X, Yang J, Zhang F, Chen K, Jiang C, Zhou Y, Bai W, Li L, Zhou Y, Lv XB.   +12 more
europepmc   +1 more source

Integrate single-cell and transcriptome analyses to explore the prognostic genes related to TRPM4 in bladder cancer. [PDF]

Front Bioeng Biotechnol
Zhao Q, Qin Z, Liu R, Zuo K, Guo C, Jing S, Li W.   +6 more
europepmc   +1 more source

Characteristics of The Cancer Genome Atlas cases relative to U.S. general population cancer cases [PDF]

, 2018
Bailey, Matthew H, Feng, Qianxi, Johnson, Kimberly J, Padda, Hannah, Steensma, Joseph T, Wang, Xiaoyan   +5 more
core   +1 more source

TRIM28 orchestrates SUMO-ubiquitin crosstalk to stabilize PPARG and drive bladder cancer progression. [PDF]

Cell Death Dis
Fan X, Li Z, Gao Q, Huang P, Li Z, Lu D, Wang L, Xiang P, Huang T, Shen D, Xiao J.   +10 more
europepmc   +1 more source

Retraction: Mechanistic Analysis of the Role of BLCA-4 in Bladder Cancer Pathobiology [PDF]

Cancer Research, 2014
openaire   +1 more source

AKAP7 is a prognostic biomarker involved in immune infiltration of bladder urothelial carcinoma and correlated with ferroptosis. [PDF]

Discov Oncol
Liu H, Mao Q, Wang X, Tang G, Ding G, Wang T, Liu C, Ma X, Cui Y, Wu J.   +9 more
europepmc   +1 more source

In-silico discovery of cancer-specific peptide-HLA complexes for targeted therapy [PDF]

, 2016

core   +1 more source

TNFRSF17 as a complementary biomarker to PD-L1 for predicting the response to immunotherapy in urothelial bladder cancer. [PDF]

PLoS One
Chen J, Li B, Gan Y, Li P.
europepmc   +1 more source

Leveraging untargeted metabolomics in combination with machine learning to uncover novel insights into bladder cancer. [PDF]

Cancer Metab
Kamal AHM, Putluri V, Gandhi T, Ambati CSR, Amara CS, Kami Reddy KR, Spradlin ML, Koirala A, Jorvekar SB, Grimm SL, Fu D, Parsawar K, Jong F, Beecher C, Sen S, Lerner SP, Siddiqui MM, Lotan Y, Eberlin LS, Sreekumar A, Coarfa C, Putluri N.   +21 more
europepmc   +1 more source

Dysregulated Peroxiredoxins in Bladder Cancer Are Associated With an Altered Tumour Immune Microenvironment. [PDF]

J Cell Mol Med
Wallerson J, Rostampour S, Teng S, Kidane D.   +3 more
europepmc   +1 more source